trending Market Intelligence /marketintelligence/en/news-insights/trending/hXpeLuHcbdY4f4JJGg-Z_g2 content esgSubNav
In This List

Interleukin board member to resign

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Interleukin board member to resign

Roger Colman is resigning from the Interleukin Genetics Inc. board on Dec. 30.

He was nominated by Pyxis Innovations Inc. following an investment in Interleukin Genetics. Colman is also retiring from Pyxis.

Pyxis Innovations can appoint two directors to the Interleukin Genetics board but is waiving off its right to name a replacement for Colman.

Joseph Landstra continues to represent Pyxis on the Interleukin board.